Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Maureen A. ter Laak"'
Autor:
Dimitri N.M. Papatsonis, Maureen A. ter Laak, Paul R.M. van Hattum, Frederik K. Lotgering, Martina Porath, Mariëlle G. van Pampus, Marc E. A. Spaanderman, Carolien Roos, Anneke Kwee, Nils E. van 't Veer, Joris A. M. van der Post, Daan J Touw, Ben W.J. Mol
Publikováno v:
International Journal of Clinical Pharmacology and Therapeutics, 53, 84-91
International Journal of Clinical Pharmacology and Therapeutics, 53, 1, pp. 84-91
International journal of clinical pharmacology and therapeutics, 53(1), 84-91. Dustri-Verlag Dr. Karl Feistle
International Journal of Clinical Pharmacology and Therapeutics, 53, 1, pp. 84-91
International journal of clinical pharmacology and therapeutics, 53(1), 84-91. Dustri-Verlag Dr. Karl Feistle
Item does not contain fulltext OBJECTIVE: The pharmacokinetics of nifedipine as a tocolytic agent has not been studied in great detail in pregnant women and has instead focused on immediate release tablets and gastrointestinal therapeutic system (GIT
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a67395fb3c616504fa5124b0f5f49782
https://hdl.handle.net/2066/153645
https://hdl.handle.net/2066/153645
Autor:
Alphons H. Temmink, Paul R.M. van Hattum, Nils E. van 't Veer, Christa M. Cobbaert, Maureen A. ter Laak, Ankie Koeken
Publikováno v:
Pediatric Neurology. 43:159-162
Ten out of 100 children treated for attention deficit hyperactivity disorder with standard doses of atomoxetine were selected by a neurologist for cytochrome P450 2D6 and cytochrome P450 2C19 genotyping, based on late response (>9 weeks) and adverse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1360c2582c5a0c9fb8a8761f3bc5c33
https://doi.org/10.1016/j.pediatrneurol.2010.04.004
https://doi.org/10.1016/j.pediatrneurol.2010.04.004